Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 110

1.

Detection of BRAF mutations on direct smears of thyroid fine-needle aspirates through cell transfer technique.

Shi Q, Ibrahim A, Herbert K, Carvin M, Randolph M, Post KM, Curless K, Chen S, Cramer HM, Cheng L, Wu HH.

Am J Clin Pathol. 2015 Apr;143(4):500-4. doi: 10.1309/AJCP5BG0KUEOJCVS.

2.

Allele-specific PCR with competitive probe blocking for sensitive and specific detection of BRAF V600E in thyroid fine-needle aspiration specimens.

Smith GD, Zhou L, Rowe LR, Jarboe EA, Collins BT, Bentz JS, Wittwer CT, Chadwick BE.

Acta Cytol. 2011;55(6):576-83. doi: 10.1159/000333453. Epub 2011 Dec 9.

PMID:
22156469
3.

Detection of PAX8/PPARG and RET/PTC rearrangements is feasible in routine air-dried fine needle aspiration smears.

Ferraz C, Rehfeld C, Krogdahl A, Precht Jensen EM, Bösenberg E, Narz F, Hegedüs L, Paschke R, Eszlinger M.

Thyroid. 2012 Oct;22(10):1025-30. doi: 10.1089/thy.2011.0391.

4.

Use of BRAF v600e immunocytochemistry on FNA direct smears of papillary thyroid carcinoma.

Wobker SE, Kim LT, Hackman TG, Dodd LG.

Cancer Cytopathol. 2015 Sep;123(9):531-9. doi: 10.1002/cncy.21575. Epub 2015 Jun 16.

5.

Evaluation of a Two-Year Routine Application of Molecular Testing of Thyroid Fine-Needle Aspirations Using a Seven-Gene Panel in a Primary Referral Setting in Germany.

Eszlinger M, Böhme K, Ullmann M, Görke F, Siebolts U, Neumann A, Franzius C, Adam S, Molwitz T, Landvogt C, Amro B, Hach A, Feldmann B, Graf D, Wefer A, Niemann R, Bullmann C, Klaushenke G, Santen R, Tönshoff G, Ivancevic V, Kögler A, Bell E, Lorenz B, Kluge G, Hartenstein C, Ruschenburg I, Paschke R.

Thyroid. 2017 Mar;27(3):402-411. doi: 10.1089/thy.2016.0445. Epub 2017 Feb 7.

PMID:
28071986
6.

False-negative BRAF V600E mutation results on fine-needle aspiration cytology of papillary thyroid carcinoma.

Paek SH, Kim BS, Kang KH, Kim HS.

World J Surg Oncol. 2017 Nov 13;15(1):202. doi: 10.1186/s12957-017-1266-5.

7.

Assessment of cellularity, genomic DNA yields, and technical platforms for BRAF mutational testing in thyroid fine-needle aspirate samples.

Dyhdalo K, Macnamara S, Brainard J, Underwood D, Tubbs R, Yang B.

Cancer Cytopathol. 2014 Feb;122(2):114-22. doi: 10.1002/cncy.21356. Epub 2013 Oct 21.

8.

Utility of BRAF mutation detection in fine-needle aspiration biopsy samples read as "suspicious for papillary thyroid carcinoma".

Jara SM, Bhatnagar R, Guan H, Gocke CD, Ali SZ, Tufano RP.

Head Neck. 2015 Dec;37(12):1788-93. doi: 10.1002/hed.23829. Epub 2014 Sep 25.

PMID:
24989827
9.

Pilot of BRAF mutation analysis in indeterminate, suspicious and malignant thyroid FNA cytology.

Johnson SJ, Hardy SA, Roberts C, Bourn D, Mallick U, Perros P.

Cytopathology. 2014 Jun;25(3):146-54. doi: 10.1111/cyt.12125. Epub 2014 Jan 12.

PMID:
24417615
10.

Laser capture microdissection is a valuable tool in the preoperative molecular screening of follicular lesions of the thyroid: an institutional experience.

Bongiovanni M, Molinari F, Eszlinger M, Paschke R, Barizzi J, Merlo E, Giovanella L, Fasolini F, Cattaneo F, Ramelli F, Mazzucchelli L, Frattini M.

Cytopathology. 2015 Oct;26(5):288-96. doi: 10.1111/cyt.12226. Epub 2014 Dec 8.

PMID:
25487739
11.

BRAF mutation testing of thyroid fine-needle aspiration specimens enhances the predictability of malignancy in thyroid follicular lesions of undetermined significance.

Adeniran AJ, Hui P, Chhieng DC, Prasad ML, Schofield K, Theoharis C.

Acta Cytol. 2011;55(6):570-5. doi: 10.1159/000333274. Epub 2011 Dec 9.

PMID:
22156468
12.

Detection of BRAF c.1799T > A (p.V600E) mutation using residual routine fine-needle aspiration specimens of papillary thyroid carcinoma.

Zhao H, Zhang ZH, Zhou B, Xiao T, Pan QJ, Guo HQ.

Diagn Cytopathol. 2015 Oct;43(10):786-90. doi: 10.1002/dc.23302. Epub 2015 Jul 7.

PMID:
26152656
13.
14.
15.

Nuclear morphometric findings in undetermined cytology: A possible clue for prediction of BRAF mutation in papillary thyroid carcinomas.

Mungan S, Ersoz S, Saygin I, Sagnak Z, Cobanoglu U.

Endocr Res. 2017 May;42(2):138-144. doi: 10.1080/07435800.2016.1255895. Epub 2016 Dec 2.

PMID:
27911099
16.

Surgical perspective of T1799A BRAF mutation diagnostic value in papillary thyroid carcinoma.

Brahma B, Yulian ED, Ramli M, Setianingsih I, Gautama W, Brahma P, Sastroasmoro S, Harimurti K.

Asian Pac J Cancer Prev. 2013;14(1):31-7.

17.

BRAF mutation analysis in fine needle aspiration (FNA) cytology of the thyroid.

Jin L, Sebo TJ, Nakamura N, Qian X, Oliveira A, Majerus JA, Johnson MR, Lloyd RV.

Diagn Mol Pathol. 2006 Sep;15(3):136-43.

PMID:
16932068
18.

BRAF mutation detection in indeterminate thyroid cytology specimens: underlying cytologic, molecular, and pathologic characteristics of papillary thyroid carcinoma.

Ohori NP, Singhal R, Nikiforova MN, Yip L, Schoedel KE, Coyne C, McCoy KL, LeBeau SO, Hodak SP, Carty SE, Nikiforov YE.

Cancer Cytopathol. 2013 Apr;121(4):197-205. doi: 10.1002/cncy.21229. Epub 2012 Aug 7.

19.

Reflex BRAF testing in thyroid fine-needle aspiration biopsy with equivocal and positive interpretation: a prospective study.

Adeniran AJ, Theoharis C, Hui P, Prasad ML, Hammers L, Carling T, Udelsman R, Chhieng DC.

Thyroid. 2011 Jul;21(7):717-23. doi: 10.1089/thy.2011.0021. Epub 2011 May 13.

PMID:
21568726
20.

BRAFV600E mutation in fine-needle aspiration aspirates: Association with poorer prognostic factors in larger papillary thyroid carcinomas.

Lee JI, Jang HW, Kim SW, Kim JW, Oh YL, Chung JH.

Head Neck. 2013 Apr;35(4):548-53. doi: 10.1002/hed.22997. Epub 2012 Apr 7.

PMID:
22488961

Supplemental Content

Support Center